Argenica Therapeutics has taken a step forward in the development of its neuroprotective drug candidate ARG-007 in acute ...
Argenica Therapeutics has announced successful independent validation of its ARG-007 compound in a preclinical study using a rat model of ischemic stroke. The study confirmed that a dose of 325 ...
Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment.
Gurgaon: Hospitals have been reporting a rise in brain stroke and heart attack cases with the onset of winter and high ...
Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...
Health and Me on MSN
Weight Loss Drugs Could Now Cut Stroke Risk, Finds Study
A new meta-analysis of 31 preclinical studies suggests GLP-1 drugs like semaglutide may reduce ischemic stroke severity in ...
Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...
Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes ...
Systematic review suggests GLP-1 receptor agonists offer strong preclinical neuroprotection in nondiabetic ischemic stroke, ...
Prasugrel may be the P2Y12 inhibitor of choice for use in combination with aspirin after PCI in patients with diabetes and ...
Hyoseok Nam, Professor of Neurology at Severance Hospital, recently led the revision of the acute cerebral infarction treatment guidelines issued by ...
Inflammatory biomarkers in ischemic stroke: mechanisms, clinical applications, and future directions
Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback